EICHOR
● Active Not Recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Condition: Immunoglobulin A Nephropathy · Sponsor: Alpine Immune Sciences Inc, A Subsidiary of Vertex
About this study
The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserving renal function.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (318)
| Apogee Clinical Research, LLC | Huntsville, Alabama, United States | — |
| Arizona Kidney Disease and Hypertension Center - Thomas Office | Phoenix, Arizona, United States | — |
| Arizona Kidney Disease and Hypertension Center - Tuscon | Tucson, Arizona, United States | — |
| West Coast Kidney | Fremont, California, United States | — |
| The Medical Research Group, Inc. (FRENOVA) | Fresno, California, United States | — |
| CARE Institute - Carabello Kidney | Los Angeles, California, United States | — |
| Providence Medical Foundation - Orange | Orange, California, United States | — |
| National Nephrology Alliance Research | Riverside, California, United States | — |
| UC Davis Health | Sacramento, California, United States | — |
| Zuckerberg San Francisco General Hospital and Trauma Center | San Francisco, California, United States | — |
| University of California San Francisco (UCSF) | San Francisco, California, United States | — |
| Western Nephrology | Arvada, Colorado, United States | — |
+ 306 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06564142